EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Three-Year Outcomes After Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Chronic Rhinitis

Jivianne T Lee iD, Gregory M Abbas, Daniel D Charous, Mandy Cuevas, Önder Göktas, Patricia A Loftus, Nathan E Nachlas, Elina M Toskala, Jeremy P Watkins, Detlef Brehmer iD

American Journal of Rhinology & Allergy · 2025

DOI: 10.1177/19458924251360889 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift American Journal of Rhinology & Allergy, 2025. Verfasst von Jivianne T Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Nose, Radiofrequency Ablation, Rhinitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic rhinitis (CR) is characterized by refractory symptoms such as rhinorrhea, sneezing, nasal congestion, postnasal drip (PND), and cough. Most patients do not achieve lasting symptom relief with medical management.

Objective

To evaluate the long-term efficacy and safety of temperature-controlled radiofrequency treatment targeting posterior nasal nerves (PNNs) for CR.

Methods

This prospective, single-arm, open-label, multicenter study included patients aged 18–85 years across 19 centers in the United States and Germany. Outcome measures included reflective Total Nasal Symptom Score (rTNSS), PND and cough scores, and the Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ). Outcomes, including adverse events, were reported through 3 years post-procedure.

Setting

All procedures were performed in an outpatient office-based setting.

Results

One hundred twenty-nine patients received treatment; 101 completed 3-year follow-up. The adjusted mean rTNSS Score improved from 7.8 (95% confidence interval [CI]: 7.5-8.1) at baseline to 3.2 (95% CI: 2.8-3.7) at 3 years (mean change: −4.5 [95% CI: −5.1 to −4.0]; P < .001). Rhinorrhea symptom scores improved from 2.6 to 1.2 (55.8% reduction). Compared to baseline, at 3 years, adjusted mean cough and PND scores declined from 1.3 to 0.4 (mean change: −0.9; P < .001, 69% reduction) and from 2.4 to 1.2 (mean change: −1.2; P < .001, 50% reduction), respectively. MiniRQLQ scores were significantly reduced from an adjusted mean of 3.0 (95% CI: 2.8-3.2) at baseline to 1.2 (95% CI: 1.0-1. 4) at 3-year follow-up; P < .001. No serious device- or procedure-related adverse events were reported.

Conclusion

A single temperature-controlled radiofrequency treatment of the PNN safely and effectively reduced CR symptoms, including cough and PND, improved quality of life, and decreased medication burden through a period of 3 years with no serious adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NoseRadiofrequency AblationRhinitisAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultChronic DiseaseFollow-Up StudiesProspective StudiesQuality of LifeSurveys and QuestionnairesTreatment OutcomeUnited States

Stichwörter der Autor:innen

ablationallergic rhinitischronic rhinitiscongestionneurolysisposterior nasal nervepostnasal driprTNSStemperature-controlled radiofrequencyvasomotor rhinitis

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Advanced ENT and Allergy, Louisville, KY, USA.
  • Arizona Desert Ear, Nose & Throat Specialists, Goodyear, AZ, USA.
  • Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • ENT-Center, HNO-Zentrum am Kudamm, Berlin, Germany.
  • Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, CA, USA.

ORCID-Profile: Jivianne T Lee, Detlef Brehmer

Zitieren

APA

Lee, J. T., Abbas, G. M., Charous, D. D., Cuevas, M., Göktas, Ö., Loftus, P. A., Nachlas, N. E., Toskala, E. M., Watkins, J. P., & Brehmer, D. (2025). Three-Year Outcomes After Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Chronic Rhinitis. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924251360889

Vancouver

Lee JT, Abbas GM, Charous DD, Cuevas M, Göktas Ö, Loftus PA, et al. Three-Year Outcomes After Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Chronic Rhinitis. American Journal of Rhinology & Allergy. 2025. doi:10.1177/19458924251360889

BibTeX
@article{Lee2025,
  author = {Lee, Jivianne T and Abbas, Gregory M and Charous, Daniel D and Cuevas, Mandy and Göktas, Önder and Loftus, Patricia A and Nachlas, Nathan E and Toskala, Elina M and Watkins, Jeremy P and Brehmer, Detlef},
  title = {Three-Year Outcomes After Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve for Chronic Rhinitis},
  journal = {American Journal of Rhinology & Allergy},
  year = {2025},
  doi = {10.1177/19458924251360889}
}
Kostenlos starten →